Clinical Trial Update: A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating the safety and potential benefit of Vitamin B5 (pantothenic acid) in patients with melanoma. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Vitamin B5 (pantothenic acid)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Melanoma (Skin) | Phase 1 | Status: RECRUITING